Annual CFF
$32.84 M
+$66.16 M+198.52%
31 March 2024
Summary:
Mesa Laboratories annual cash flow from financing activities is currently $32.84 million, with the most recent change of +$66.16 million (+198.52%) on 31 March 2024. During the last 3 years, it has fallen by -$113.39 million (-77.54%). MLAB annual CFF is now -85.80% below its all-time high of $231.28 million, reached on 31 March 2020.MLAB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$8.61 M
+$499.00 K+5.48%
30 September 2024
Summary:
Mesa Laboratories quarterly cash flow from financing activities is currently -$8.61 million, with the most recent change of +$499.00 thousand (+5.48%) on 30 September 2024. Over the past year, it has dropped by -$3.05 million (-54.86%). MLAB quarterly CFF is now -103.71% below its all-time high of $232.16 million, reached on 30 September 2019.MLAB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$30.20 M
-$3.05 M-9.17%
30 September 2024
Summary:
Mesa Laboratories TTM cash flow from financing activities is currently $30.20 million, with the most recent change of -$3.05 million (-9.17%) on 30 September 2024. Over the past year, it has increased by +$58.55 million (+206.50%). MLAB TTM CFF is now -92.03% below its all-time high of $379.08 million, reached on 30 June 2020.MLAB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLAB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +198.5% | -54.9% | +206.5% |
| 3 y3 years | -77.5% | -843.5% | +5420.3% |
| 5 y5 years | +251.5% | -103.7% | -86.3% |
MLAB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -77.5% | +198.5% | -114.1% | +53.8% | -51.0% | +172.9% |
| 5 y | 5 years | -85.8% | +198.5% | -103.7% | +53.8% | -92.0% | +172.9% |
| alltime | all time | -85.8% | +198.5% | -103.7% | +53.8% | -92.0% | +172.9% |
Mesa Laboratories Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.61 M(-5.5%) | $30.20 M(-9.2%) |
| June 2024 | - | -$9.11 M(-29.6%) | $33.25 M(+1.2%) |
| Mar 2024 | $32.84 M(-198.5%) | -$12.93 M(-121.3%) | $32.84 M(-20.6%) |
| Dec 2023 | - | $60.85 M(-1194.4%) | $41.38 M(-245.9%) |
| Sept 2023 | - | -$5.56 M(-41.6%) | -$28.35 M(-31.6%) |
| June 2023 | - | -$9.52 M(+116.7%) | -$41.44 M(+24.3%) |
| Mar 2023 | -$33.33 M(-163.4%) | -$4.39 M(-50.6%) | -$33.33 M(-14.5%) |
| Dec 2022 | - | -$8.88 M(-52.4%) | -$38.98 M(-225.3%) |
| Sept 2022 | - | -$18.65 M(+1225.2%) | $31.10 M(-38.9%) |
| June 2022 | - | -$1.41 M(-86.0%) | $50.90 M(-3.2%) |
| Mar 2022 | $52.58 M(-64.0%) | -$10.05 M(-116.4%) | $52.58 M(-14.6%) |
| Dec 2021 | - | $61.20 M(+5185.0%) | $61.58 M(>+9900.0%) |
| Sept 2021 | - | $1.16 M(+337.0%) | $547.00 K(-239.5%) |
| June 2021 | - | $265.00 K(-125.3%) | -$392.00 K(-100.3%) |
| Mar 2021 | $146.23 M(-36.8%) | -$1.05 M(-712.3%) | $146.23 M(-1.0%) |
| Dec 2020 | - | $171.00 K(-21.9%) | $147.67 M(+0.4%) |
| Sept 2020 | - | $219.00 K(-99.9%) | $147.14 M(-61.2%) |
| June 2020 | - | $146.88 M(>+9900.0%) | $379.08 M(+63.9%) |
| Mar 2020 | $231.28 M(-1167.2%) | $394.00 K(-210.4%) | $231.28 M(+2.7%) |
| Dec 2019 | - | -$357.00 K(-100.2%) | $225.27 M(+2.0%) |
| Sept 2019 | - | $232.16 M(<-9900.0%) | $220.87 M(-1317.2%) |
| June 2019 | - | -$915.00 K(-83.7%) | -$18.14 M(-16.3%) |
| Mar 2019 | -$21.67 M(+140.2%) | -$5.62 M(+18.0%) | -$21.67 M(-16.5%) |
| Dec 2018 | - | -$4.76 M(-30.6%) | -$25.96 M(+42.8%) |
| Sept 2018 | - | -$6.86 M(+54.4%) | -$18.19 M(+89.9%) |
| June 2018 | - | -$4.44 M(-55.2%) | -$9.58 M(+6.1%) |
| Mar 2018 | -$9.02 M(-882.0%) | -$9.91 M(-428.0%) | -$9.02 M(+33.4%) |
| Dec 2017 | - | $3.02 M(+72.5%) | -$6.77 M(-25.5%) |
| Sept 2017 | - | $1.75 M(-145.0%) | -$9.08 M(+123.6%) |
| June 2017 | - | -$3.89 M(-49.2%) | -$4.06 M(-451.9%) |
| Mar 2017 | $1.15 M(-93.8%) | -$7.65 M(-1182.2%) | $1.15 M(-82.5%) |
| Dec 2016 | - | $707.00 K(-89.6%) | $6.60 M(+1.3%) |
| Sept 2016 | - | $6.77 M(+410.2%) | $6.52 M(-69.3%) |
| June 2016 | - | $1.33 M(-160.2%) | $21.21 M(+13.9%) |
| Mar 2016 | $18.62 M(+105.2%) | -$2.21 M(-453.5%) | $18.62 M(-1.4%) |
| Dec 2015 | - | $624.00 K(-97.1%) | $18.88 M(-6.6%) |
| Sept 2015 | - | $21.46 M(-1804.6%) | $20.21 M(-662.0%) |
| June 2015 | - | -$1.26 M(-35.3%) | -$3.60 M(-139.6%) |
| Mar 2015 | $9.07 M(-26.4%) | -$1.95 M(-199.5%) | $9.07 M(-22.9%) |
| Dec 2014 | - | $1.96 M(-183.4%) | $11.77 M(-54.3%) |
| Sept 2014 | - | -$2.35 M(-120.6%) | $25.73 M(-3.1%) |
| June 2014 | - | $11.41 M(+1423.2%) | $26.55 M(+115.3%) |
| Mar 2014 | $12.33 M(+313.8%) | $749.00 K(-95.3%) | $12.33 M(+21.3%) |
| Dec 2013 | - | $15.91 M(-1145.0%) | $10.17 M(-212.6%) |
| Sept 2013 | - | -$1.52 M(-45.7%) | -$9.03 M(-15.3%) |
| June 2013 | - | -$2.81 M(+98.4%) | -$10.66 M(-457.6%) |
| Mar 2013 | $2.98 M(-140.2%) | -$1.42 M(-57.0%) | $2.98 M(+20.3%) |
| Dec 2012 | - | -$3.29 M(+4.4%) | $2.48 M(-20.5%) |
| Sept 2012 | - | -$3.15 M(-129.1%) | $3.12 M(-13.5%) |
| June 2012 | - | $10.84 M(-665.2%) | $3.60 M(-148.5%) |
| Mar 2012 | -$7.42 M(-253.9%) | -$1.92 M(-27.7%) | -$7.42 M(+26.7%) |
| Dec 2011 | - | -$2.65 M(-0.5%) | -$5.86 M(+365.1%) |
| Sept 2011 | - | -$2.66 M(+1279.8%) | -$1.26 M(-264.1%) |
| June 2011 | - | -$193.00 K(-45.3%) | $768.00 K(-84.1%) |
| Mar 2011 | $4.83 M(-431.4%) | -$353.00 K(-118.1%) | $4.83 M(-1.3%) |
| Dec 2010 | - | $1.95 M(-406.9%) | $4.89 M(+100.0%) |
| Sept 2010 | - | -$635.00 K(-116.4%) | $2.44 M(-11.6%) |
| June 2010 | - | $3.86 M(-1427.8%) | $2.76 M(-289.8%) |
| Mar 2010 | -$1.46 M(+21.0%) | -$291.00 K(-41.2%) | -$1.46 M(-1.1%) |
| Dec 2009 | - | -$495.00 K(+57.1%) | -$1.47 M(+16.9%) |
| Sept 2009 | - | -$315.00 K(-11.3%) | -$1.26 M(-1.8%) |
| June 2009 | - | -$355.00 K(+15.6%) | -$1.28 M(+6.6%) |
| Mar 2009 | -$1.20 M(-34.6%) | -$307.00 K(+8.9%) | -$1.20 M(-2.6%) |
| Dec 2008 | - | -$282.00 K(-16.6%) | -$1.24 M(-17.7%) |
| Sept 2008 | - | -$338.00 K(+22.5%) | -$1.50 M(-4.3%) |
| June 2008 | - | -$276.00 K(-18.6%) | -$1.57 M(-14.8%) |
| Mar 2008 | -$1.84 M(+13.6%) | -$339.00 K(-38.1%) | -$1.84 M(-4.5%) |
| Dec 2007 | - | -$548.00 K(+35.3%) | -$1.93 M(-6.3%) |
| Sept 2007 | - | -$405.00 K(-26.1%) | -$2.06 M(+6.5%) |
| June 2007 | - | -$548.00 K(+28.6%) | -$1.93 M(+19.3%) |
| Mar 2007 | -$1.62 M | -$426.00 K(-37.2%) | -$1.62 M(-9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | - | -$678.00 K(+142.1%) | -$1.80 M(-19.2%) |
| Sept 2006 | - | -$280.00 K(+18.6%) | -$2.22 M(-33.4%) |
| June 2006 | - | -$236.00 K(-60.9%) | -$3.34 M(-0.7%) |
| Mar 2006 | -$3.36 M(+45.1%) | -$603.00 K(-45.4%) | -$3.36 M(+8.1%) |
| Dec 2005 | - | -$1.10 M(-20.7%) | -$3.11 M(-10.7%) |
| Sept 2005 | - | -$1.39 M(+436.2%) | -$3.48 M(+48.7%) |
| June 2005 | - | -$260.00 K(-25.7%) | -$2.34 M(+1.0%) |
| Mar 2005 | -$2.32 M(+88.1%) | -$350.00 K(-76.3%) | -$2.32 M(+3.5%) |
| Dec 2004 | - | -$1.48 M(+478.8%) | -$2.24 M(+82.7%) |
| Sept 2004 | - | -$255.00 K(+8.1%) | -$1.23 M(+6.7%) |
| June 2004 | - | -$236.00 K(-13.2%) | -$1.15 M(-6.7%) |
| Mar 2004 | -$1.23 M(-19.7%) | -$272.00 K(-41.2%) | -$1.23 M(+10.4%) |
| Dec 2003 | - | -$462.80 K(+159.7%) | -$1.12 M(-34.8%) |
| Sept 2003 | - | -$178.20 K(-44.1%) | -$1.71 M(+2.3%) |
| June 2003 | - | -$319.00 K(+104.0%) | -$1.67 M(+9.0%) |
| Mar 2003 | -$1.53 M(+43.5%) | -$156.40 K(-85.2%) | -$1.53 M(+3.6%) |
| Dec 2002 | - | -$1.06 M(+657.7%) | -$1.48 M(+150.7%) |
| Sept 2002 | - | -$139.60 K(-22.8%) | -$590.80 K(-34.2%) |
| June 2002 | - | -$180.90 K(+75.3%) | -$897.60 K(-16.1%) |
| Mar 2002 | -$1.07 M(-28.6%) | -$103.20 K(-38.2%) | -$1.07 M(-35.7%) |
| Dec 2001 | - | -$167.10 K(-62.6%) | -$1.66 M(-2.5%) |
| Sept 2001 | - | -$446.40 K(+26.5%) | -$1.71 M(+9.3%) |
| June 2001 | - | -$353.00 K(-49.5%) | -$1.56 M(+4.2%) |
| Mar 2001 | -$1.50 M(-23.9%) | -$698.40 K(+232.3%) | -$1.50 M(+9.5%) |
| Dec 2000 | - | -$210.20 K(-30.1%) | -$1.37 M(+29.3%) |
| Sept 2000 | - | -$300.60 K(+3.8%) | -$1.06 M(-27.4%) |
| June 2000 | - | -$289.50 K(-49.1%) | -$1.46 M(-25.9%) |
| Mar 2000 | -$1.97 M(+40.6%) | -$569.00 K(-669.0%) | -$1.97 M(+15.8%) |
| Dec 1999 | - | $100.00 K(-114.3%) | -$1.70 M(-10.5%) |
| Sept 1999 | - | -$700.00 K(-12.5%) | -$1.90 M(-9.5%) |
| June 1999 | - | -$800.00 K(+166.7%) | -$2.10 M(+50.0%) |
| Mar 1999 | -$1.40 M(+180.0%) | -$300.00 K(+200.0%) | -$1.40 M(0.0%) |
| Dec 1998 | - | -$100.00 K(-88.9%) | -$1.40 M(0.0%) |
| Sept 1998 | - | -$900.00 K(+800.0%) | -$1.40 M(+180.0%) |
| June 1998 | - | -$100.00 K(-66.7%) | -$500.00 K(0.0%) |
| Mar 1998 | -$500.00 K(+150.0%) | -$300.00 K(+200.0%) | -$500.00 K(+150.0%) |
| Dec 1997 | - | -$100.00 K(<-9900.0%) | -$200.00 K(-33.3%) |
| Sept 1997 | - | $0.00(-100.0%) | -$300.00 K(0.0%) |
| June 1997 | - | -$100.00 K(<-9900.0%) | -$300.00 K(+50.0%) |
| Mar 1997 | -$200.00 K(-300.0%) | $0.00(-100.0%) | -$200.00 K(0.0%) |
| Dec 1996 | - | -$200.00 K(<-9900.0%) | -$200.00 K(-300.0%) |
| Sept 1996 | - | $0.00(0.0%) | $100.00 K(0.0%) |
| June 1996 | - | $0.00(0.0%) | $100.00 K(0.0%) |
| Mar 1996 | $100.00 K(-125.0%) | $0.00(-100.0%) | $100.00 K(>+9900.0%) |
| Dec 1995 | - | $100.00 K(>+9900.0%) | $0.00(-100.0%) |
| Sept 1995 | - | $0.00(0.0%) | -$200.00 K(-33.3%) |
| June 1995 | - | $0.00(-100.0%) | -$300.00 K(-25.0%) |
| Mar 1995 | -$400.00 K(+33.3%) | -$100.00 K(0.0%) | -$400.00 K(0.0%) |
| Dec 1994 | - | -$100.00 K(0.0%) | -$400.00 K(+33.3%) |
| Sept 1994 | - | -$100.00 K(0.0%) | -$300.00 K(+50.0%) |
| June 1994 | - | -$100.00 K(0.0%) | -$200.00 K(-33.3%) |
| Mar 1994 | -$300.00 K(<-9900.0%) | -$100.00 K(<-9900.0%) | -$300.00 K(-25.0%) |
| Dec 1993 | - | $0.00(0.0%) | -$400.00 K(0.0%) |
| Sept 1993 | - | $0.00(-100.0%) | -$400.00 K(0.0%) |
| June 1993 | - | -$200.00 K(0.0%) | -$400.00 K(<-9900.0%) |
| Mar 1993 | $0.00(-100.0%) | -$200.00 K(<-9900.0%) | $0.00(0.0%) |
| Dec 1992 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1992 | - | $0.00(-100.0%) | $0.00(0.0%) |
| June 1992 | - | $200.00 K(-200.0%) | $0.00(-100.0%) |
| Mar 1992 | -$300.00 K(-25.0%) | -$200.00 K(<-9900.0%) | -$300.00 K(+50.0%) |
| Dec 1991 | - | $0.00(0.0%) | -$200.00 K(-33.3%) |
| Sept 1991 | - | $0.00(-100.0%) | -$300.00 K(-25.0%) |
| June 1991 | - | -$100.00 K(0.0%) | -$400.00 K(0.0%) |
| Mar 1991 | -$400.00 K(-200.0%) | -$100.00 K(0.0%) | -$400.00 K(+33.3%) |
| Dec 1990 | - | -$100.00 K(0.0%) | -$300.00 K(+50.0%) |
| Sept 1990 | - | -$100.00 K(0.0%) | -$200.00 K(+100.0%) |
| June 1990 | - | -$100.00 K(<-9900.0%) | -$100.00 K(-125.0%) |
| Mar 1990 | $400.00 K | $0.00(0.0%) | $400.00 K(0.0%) |
| Dec 1989 | - | $0.00(0.0%) | $400.00 K(0.0%) |
| Sept 1989 | - | $0.00(-100.0%) | $400.00 K(0.0%) |
| June 1989 | - | $400.00 K | $400.00 K |
FAQ
- What is Mesa Laboratories annual cash flow from financing activities?
- What is the all time high annual CFF for Mesa Laboratories?
- What is Mesa Laboratories annual CFF year-on-year change?
- What is Mesa Laboratories quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Mesa Laboratories?
- What is Mesa Laboratories quarterly CFF year-on-year change?
- What is Mesa Laboratories TTM cash flow from financing activities?
- What is the all time high TTM CFF for Mesa Laboratories?
- What is Mesa Laboratories TTM CFF year-on-year change?
What is Mesa Laboratories annual cash flow from financing activities?
The current annual CFF of MLAB is $32.84 M
What is the all time high annual CFF for Mesa Laboratories?
Mesa Laboratories all-time high annual cash flow from financing activities is $231.28 M
What is Mesa Laboratories annual CFF year-on-year change?
Over the past year, MLAB annual cash flow from financing activities has changed by +$66.16 M (+198.52%)
What is Mesa Laboratories quarterly cash flow from financing activities?
The current quarterly CFF of MLAB is -$8.61 M
What is the all time high quarterly CFF for Mesa Laboratories?
Mesa Laboratories all-time high quarterly cash flow from financing activities is $232.16 M
What is Mesa Laboratories quarterly CFF year-on-year change?
Over the past year, MLAB quarterly cash flow from financing activities has changed by -$3.05 M (-54.86%)
What is Mesa Laboratories TTM cash flow from financing activities?
The current TTM CFF of MLAB is $30.20 M
What is the all time high TTM CFF for Mesa Laboratories?
Mesa Laboratories all-time high TTM cash flow from financing activities is $379.08 M
What is Mesa Laboratories TTM CFF year-on-year change?
Over the past year, MLAB TTM cash flow from financing activities has changed by +$58.55 M (+206.50%)